Collard Craig A sold HRTX

January 19, 2024 · Form 4 insider transaction

Collard Craig A sold 13,797 shares of Heron Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 91 days after the transaction.

Direction

Disposed (sell-side)

13,797

Price

$0.00

Total value

N/A

InsiderCollard Craig A

RoleOfficer, Director

CompanyHeron Therapeutics, Inc. (HRTX)

SecurityRestricted Stock Units

Transaction codeM — Option exercise

Transaction dateJanuary 19, 2024

Filing dateApril 19, 2024

Shares owned after206,953

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).

View the original Form 4 on SEC EDGAR